# Clinical Performance of the Bioperio® Protocol to Manage Periodontitis

**Authors:** Filippo Graziani, Enrica Conticini, Laura Bettini, Greta Ciardelli, Serena Leuci, Crystal Marruganti, Rossana Izzetti

PMC · DOI: 10.3390/jcm14051738 · Journal of Clinical Medicine · 2025-03-04

## TL;DR

This study evaluates a patient-centered treatment protocol for periodontitis, showing significant improvements in clinical outcomes and patient resolution.

## Contribution

The study introduces and validates the Bioperio® protocol as a comprehensive and effective treatment framework for periodontitis management.

## Key findings

- The Bioperio® protocol achieved 75.4% pocket closure and 91.3% patient resolution in 3 months.
- Enamel matrix derivatives improved outcomes in stage III periodontitis by 15% pocket closure.
- No adverse effects were observed during the treatment protocol.

## Abstract

Objectives: The aim of this study was to describe the structure and assess the efficacy of a patient-centered framework for managing periodontitis, utilizing the Bioperio® protocol, a standardized treatment approach incorporating both clinical and extra-clinical phases. Methods: Patients diagnosed with periodontitis were included in this multicenter, single-arm, clinical observational study with a 3-month follow-up. All patients were treated following the Bioperio® protocol, involving professional supra-gingival scaling, oral hygiene instructions, and scaling and root planing following a full-mouth approach. In Stage III/IV periodontitis cases, enamel matrix derivatives (EMD) were applied in periodontal pockets > 5 mm. Monthly recalls were performed until the 3-month follow-up. Results: In total, 663 patients were enrolled, with 76.4% being diagnosed with Stage II/III periodontitis. At 3 months, all clinical periodontal parameters improved regardless of the initial stage of periodontitis, achieving pocket closure in 75.4% of cases and patient resolution in 91.3% of the sample. Stages I/II showed significantly improved outcomes compared to Stage IV. The adjunct of EMDproved beneficial, especially in stage III patients, increasing pocket closure by 15% and doubling the odds of patient resolution. No adverse effects of the treatment protocol were observed throughout the study. Conclusions: The Bioperio® protocol appears to be a safe and effective therapeutic approach for the management of patients affected by periodontitis. Combining a stepwise approach for clinical phases with tailored oral hygiene instructions and motivational sessions offers a comprehensive strategy that may enhance outcomes for patients with periodontitis.

## Linked entities

- **Diseases:** periodontitis (MONDO:0005076)

## Full-text entities

- **Diseases:** Periodontitis (MESH:D010518)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11901086/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11901086/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC11901086/full.md

---
Source: https://tomesphere.com/paper/PMC11901086